GLP-1 Drugs Cut Stroke Risk 17%, But Blood Pressure Explains Only 4%
Across 7 randomized controlled trials enrolling 50,617 adults with type 2 diabetes at high cardiovascular risk, GLP-1…
Across 7 randomized controlled trials enrolling 50,617 adults with type 2 diabetes at high cardiovascular risk, GLP-1…
An AI model applied to standard 12-lead ECG images demonstrated exceptional performance in identifying hypertrophic…
Stopping a GLP-1 receptor agonist or tirzepatide isn't a neutral event — emerging evidence suggests it may set off a…
Across 52,718 UK Biobank participants followed for 12 years, accelerated biological aging — measured via Phenotypic…
Docetaxel and other DNA-damaging chemotherapies reliably induce cellular senescence in prostate cancer cells, but the…
Tuberculosis remains one of the most consequential and underappreciated infectious threats in global health — and new…
Polypharmacy in older adults is one of the most underappreciated drivers of adverse health outcomes, hospitalizations…
As GLP-1 receptor agonists move rapidly from adult obesity clinics into pediatric practice, a critical question has…
Congenital cytomegalovirus is the most common non-genetic cause of childhood sensorineural hearing loss, affecting…
A central assumption in metabolic pharmacology has been that stimulating the beta2-adrenergic receptor could unlock…
Alcoholic liver disease has quietly become one of the most demographically revealing mirrors of American public health…
Cardiovascular disease is the leading cause of premature death in systemic lupus erythematosus, a population already…
For decades, pharmaceutical scientists have relied on laboratory flasks to predict how drug coatings dissolve inside…
For one of the rarest and most lethal kidney cancers—renal medullary carcinoma (RMC)—clinicians have historically…
Continuous, unobtrusive monitoring of vulnerable patients has long been a pain point in inpatient care — standard…
Even aggressive statin therapy leaves a troubling gap in cardiovascular protection — residual risk that conventional…
Controlling neuroinflammation has emerged as one of the most promising — and frustratingly elusive — targets in…
Cardiotoxicity from doxorubicin — one of oncology's most effective but damaging chemotherapeutics — remains a poorly…
The dominant narrative in cardiovascular prevention has long centered on diet, exercise, genetics, and smoking. A…
Understanding why inherited blindness progresses so relentlessly has stumped researchers for decades, partly because…
Get daily health research summaries delivered to your inbox.
Browse our synthesized research summaries by topic. We cover the latest findings from journals like Nature Medicine, The Lancet, Cell Metabolism, and 100+ other peer-reviewed sources.